- Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
-
Sunok Park, Kyeong Min Lee, Yong Sun Yoo, Jung Sik Yoo, Jae Il Yoo, Hwa Su Kim, Yeong Seon Lee, Gyung Tae Chung
-
Osong Public Health Res Perspect. 2011;2(3):164-170. Published online December 31, 2011
-
DOI: https://doi.org/10.1016/j.phrp.2011.11.040
-
-
3,375
View
-
19
Download
-
37
Crossref
-
 Abstract
 PDF
- Objectives
This study investigated the fluoroquinolone-resistant mechanism of 56 clinical cases of A baumannii infection from 23 non-tertiary hospitals, collected between 2004 and 2006.
Methods
Susceptibility testing was performed by broth microdilution and Epsilometer test. Analyses of quinolone resistance-determining region (QRDR) were done by sequencing. The activity of the efflux pump was measured using inhibitors.
Results
The sequences from selected 56 isolates were divided into seven groups (I-VII) on the basis of mutations in gyrA (S83L), parC (S80L, S80W and S84K) and gyrB (containing the novel mutations E679D, D644Y and A677V). The 27 isolates with triple mutations in gyrA, gyrB and parC (groups IV-VII) showed higher levels of resistance to ciprofloxacin (minimal inhibitory concentration [MIC] of 16-256 μg/mL) than the 26 isolates with double mutations in gyrA and parC (groups II and III, MIC of 8-64 μ g/mL; p < 0.05). Alterations in the efflux pump were observed in four isolates with the parC S80L mutation (group II) or E84K mutation (group VII), but no effect was observed in an isolate with the parC S80 W mutation (group III).
Conclusion
These results suggest that triple mutations in clinical isolates of A baumannii contribute to the development of high levels of resistance to fluoroquinolones and that mutations in parC S80L or E84K (groups II and VII) may contribute to alterations in efflux pump activity in A baumannii.
-
Citations
Citations to this article as recorded by  - Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to Acinetobacter baumannii
Kira M. Zack, Trent Sorenson, Suresh G. Joshi
Pathogens.2024; 13(3): 197. CrossRef - Association Between Drug Efflux Pumps and Resistance to Ciprofloxacin in Clinical Isolates of Acinetobacter baumannii
Nour Amirmozafari, Azam Haddadi, Reza Mirnejad, Seyed Abdolhamid Angaji, Ebrahim Babapour
Iranian Journal of Medical Microbiology.2024; 18(2): 113. CrossRef - Antimicrobial resistance genes harbored in invasive Acinetobacter calcoaceticus-baumannii complex isolated from Korean children during the pre-COVID-19 pandemic periods, 2015–2020
Hyun Mi Kang, Kyung Ran Kim, Gahee Kim, Dong-gun Lee, Yae Jean Kim, Eun Hwa Choi, Jina Lee, Ki Wook Yun
Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef - Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation
Linda Kherroubi, Joanna Bacon, Khondaker Miraz Rahman
JAC-Antimicrobial Resistance.2024;[Epub] CrossRef - Development of Nanoparticle Adaptation Phenomena in Acinetobacter baumannii: Physiological Change and Defense Response
Oliver McNeilly, Riti Mann, Max Laurence Cummins, Steven P. Djordjevic, Mehrad Hamidian, Cindy Gunawan, Victor Gonzalez
Microbiology Spectrum.2023;[Epub] CrossRef - Colistin potentiation in multidrug-resistant Acinetobacter baumannii by a non-cytotoxic guanidine derivative of silver
Deepak Kumar, Chaitali Singhal, Manisha Yadav, Pooja Joshi, Priyanka Patra, Subhash Tanwar, Amitava Das, Sumit Kumar Pramanik, Susmita Chaudhuri
Frontiers in Microbiology.2023;[Epub] CrossRef - Phenotypic and Molecular Characteristics of Carbapenem-Resistant Acinetobacter baumannii Isolates from Bulgarian Intensive Care Unit Patients
Tanya V. Strateva, Ivo Sirakov, Temenuga J. Stoeva, Alexander Stratev, Slavil Peykov
Microorganisms.2023; 11(4): 875. CrossRef - Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii
Stefany Plasencia-Rebata, Saul Levy-Blitchtein, Juana del Valle-Mendoza, Wilmer Silva-Caso, Isaac Peña-Tuesta, William Vicente Taboada, Fernando Barreda Bolaños, Miguel Angel Aguilar-Luis
Antibiotics.2023; 12(6): 1071. CrossRef - How to treat severe Acinetobacter baumannii infections
Emilio Bouza, Patricia Muñoz, Almudena Burillo
Current Opinion in Infectious Diseases.2023; 36(6): 596. CrossRef - Comparative genotypic characterization related to antibiotic resistance phenotypes of clinical carbapenem-resistant Acinetobacter baumannii MTC1106 (ST2) and MTC0619 (ST25)
Made Rai Dwitya Wiradiputra, Krit Thirapanmethee, Piyatip Khuntayaporn, Pagakrong Wanapaisan, Mullika Traidej Chomnawang
BMC Genomics.2023;[Epub] CrossRef - A comprehensive review on potential therapeutic inhibitors of nosocomial Acinetobacter baumannii superbugs
Danaboina Srikanth, Swanand Vinayak Joshi, Mahammad Ghouse Shaik, Gaurav Pawar, Sushmitha Bujji, Vinaykumar Kanchupalli, Sidharth Chopra, Srinivas Nanduri
Bioorganic Chemistry.2022; 124: 105849. CrossRef - Differential Binding of Carbapenems with the AdeABC Efflux Pump and Modulation of the Expression of AdeB Linked to Novel Mutations within Two-Component System AdeRS in Carbapenem-Resistant Acinetobacter baumannii
Subhasree Roy, Vivek Junghare, Shanta Dutta, Saugata Hazra, Sulagna Basu, Christopher W. Marshall
mSystems.2022;[Epub] CrossRef - Antimicrobial Resistance, Integron Carriage, and Fluoroquinolone Resistance Genes in Acinetobacte baumannii Isolates
Parastoo Ashouri, Jafar Mohammadshahi, Vajihe Sadat Nikbin, Hadi Peeridogaheh, Behnam Mohammadi-Ghalehbin, Soheila Refahi, Amir Teimourpour, Majid Esmaelizad, Hafez Mirzaneghad, Roghayeh Teimourpour
Archives of Clinical Infectious Diseases.2022;[Epub] CrossRef - Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors
Privita Verma, Monalisa Tiwari, Vishvanath Tiwari
Microbial Pathogenesis.2021; 152: 104766. CrossRef - Overexpression of Efflux Pumps, Mutations in the Pumps’ Regulators, Chromosomal Mutations, and AAC(6′)-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center S
Subhasree Roy, Somdatta Chatterjee, Amrita Bhattacharjee, Pinaki Chattopadhyay, Bijan Saha, Shanta Dutta, Sulagna Basu
Frontiers in Microbiology.2021;[Epub] CrossRef - Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens
Jaime E. Zlamal, Semen A. Leyn, Mallika Iyer, Marinela L. Elane, Nicholas A. Wong, James W. Wamsley, Maarten Vercruysse, Fernando Garcia-Alcalde, Andrei L. Osterman, Igor B. Zhulin
mBio.2021;[Epub] CrossRef - Efflux Pump Activity and Mutations Driving Multidrug Resistance in Acinetobacter baumannii at a Tertiary Hospital in Pretoria, South Africa
Noel-David Nogbou, Granny M. Nkawane, Khanyisa Ntshane, Charles K. Wairuri, Dikwata T. Phofa, Kagiso K. Mokgokong, Mbudzeni Ramashia, Maphoshane Nchabeleng, Lawrence C. Obi, Andrew M. Musyoki, Todd R. Callaway
International Journal of Microbiology.2021; 2021: 1. CrossRef - The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii
Alejandra Sanchez-Carbonel, Belén Mondragón, Nicolás López-Chegne, Isaac Peña-Tuesta, Gladys Huayan-Dávila, Dora Blitchtein, Hugo Carrillo-Ng, Wilmer Silva-Caso, Miguel Angel Aguilar-Luis, Juana del Valle-Mendoza, Iddya Karunasagar
PLOS ONE.2021; 16(12): e0259915. CrossRef - Effects of different resistance mechanisms on antimicrobial resistance in Acinetobacter baumannii: a strategic system for screening and activity testing of new antibiotics
Yu-Kuo Tsai, Ci-Hong Liou, Jung-Chung Lin, Chang-Phone Fung, Feng-Yee Chang, L. Kristopher Siu
International Journal of Antimicrobial Agents.2020; 55(4): 105918. CrossRef - Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii
Corneliu Ovidiu Vrancianu, Irina Gheorghe, Ilda Barbu Czobor, Mariana Carmen Chifiriuc
Microorganisms.2020; 8(6): 935. CrossRef - Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii
Chandler Roe, Charles H. D. Williamson, Adam J. Vazquez, Kristen Kyger, Michael Valentine, Jolene R. Bowers, Paul D. Phillips, Veronica Harrison, Elizabeth Driebe, David M. Engelthaler, Jason W. Sahl
Frontiers in Public Health.2020;[Epub] CrossRef - Molecular Analyses of Biofilm-Producing Clinical Acinetobacter baumannii Isolates from a South Indian Tertiary Care Hospital
Balaram Khamari, Manmath Lama, Chanakya Pachi Pulusu, Amarendra Pratap Biswal, Sai Manoz Lingamallu, Bhargava Sai Mukkirla, Amit Kumar Sahoo, Harioum Sambhu Narayan Dash, Rewa Sharda, Prakash Kumar, Eswarappa Pradeep Bulagonda
Medical Principles and Practice.2020; 29(6): 580. CrossRef - Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania
Happiness H Kumburu, Tolbert Sonda, Marco van Zwetselaar, Pimlapas Leekitcharoenphon, Oksana Lukjancenko, Blandina T Mmbaga, Michael Alifrangis, Ole Lund, Frank M Aarestrup, Gibson S Kibiki
Journal of Antimicrobial Chemotherapy.2019; 74(6): 1484. CrossRef - Phenotypic and Genotypic Characterization of Acinetobacter spp. Panel Strains: A Cornerstone to Facilitate Antimicrobial Development
Roshan D'Souza, Naina A. Pinto, Nguyen Le Phuong, Paul G. Higgins, Thao Nguyen Vu, Jung-Hyun Byun, Young Lag Cho, Jong Rak Choi, Dongeun Yong
Frontiers in Microbiology.2019;[Epub] CrossRef - Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
David A. Butler, Mark Biagi, Xing Tan, Samah Qasmieh, Zackery P. Bulman, Eric Wenzler
Current Infectious Disease Reports.2019;[Epub] CrossRef - Molecular Study of Quinolone Resistance Determining Regions of gyrA Gene and parC Genes in Clinical Isolates of Acintobacter baumannii Resistant to Fluoroquinolone
Maysaa El Sayed Zaki, Nermen Abou ElKheir, Mohamed Mofreh
The Open Microbiology Journal.2018; 12(1): 116. CrossRef - Species distribution, virulence factors and antimicrobial resistance of Acinetobacter spp. isolates from dogs and cats: a preliminary study
Yui Kimura, Kazuki Harada, Takae Shimizu, Tomomi Sato, Akari Kajino, Masaru Usui, Yutaka Tamura, Yuzo Tsuyuki, Tadashi Miyamoto, Asami Ohki, Masahisa Watarai
Microbiology and Immunology.2018; 62(7): 462. CrossRef - Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients
Samira M. Hamed, Walid F. Elkhatib, Hadir A. El-Mahallawy, Mai M. Helmy, Mohamed S. Ashour, Khaled M. A. Aboshanab
Scientific Reports.2018;[Epub] CrossRef - Synthesis and investigation of binding interactions of 1,4-benzoxazine derivatives on topoisomerase IV in Acinetobacter baumannii
S. Yilmaz, I. Yalcin, S. Okten, F. K. Onurdag, E. Aki-Yalcin
SAR and QSAR in Environmental Research.2017; 28(11): 941. CrossRef - Antibacterial Resistance in Ureaplasma Species and Mycoplasma hominis Isolates from Urine Cultures in College-Aged Females
Marissa A. Valentine-King, Mary B. Brown
Antimicrobial Agents and Chemotherapy.2017;[Epub] CrossRef - MOLECULAR BACKGROUND OF FLUOROQUINOLONE RESISTANCE IN PATHOGENIC HUMAN MYCOPLASMAS
A. N. Vaganova
Russian Journal of Infection and Immunity.2017; 7(3): 231. CrossRef - Alarmingly High Segregation Frequencies of Quinolone Resistance Alleles within Human and Animal Microbiomes Are Not Explained by Direct Clinical Antibiotic Exposure
Wesley Field, Ruth Hershberg
Genome Biology and Evolution.2015; 7(6): 1743. CrossRef - Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei
Masayoshi Tojo, Momoko Mawatari, Kayoko Hayakawa, Maki Nagamatsu, Kayo Shimada, Kazuhisa Mezaki, Yuko Sugiki, Emi Kuroda, Nozomi Takeshita, Satoshi Kutsuna, Yoshihiro Fujiya, Tohru Miyoshi-Akiyama, Teruo Kirikae, Norio Ohmagari
Journal of Infection and Chemotherapy.2015; 21(3): 212. CrossRef - Correlation of Ciprofloxacin Resistance with the AdeABC Efflux System in Acinetobacter baumannii Clinical Isolates
Abdollah Ardebili, Abdolaziz Rastegar Lari, Malihe Talebi
Annals of Laboratory Medicine.2014; 34(6): 433. CrossRef - Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates
Abdollah Ardebili, Malihe Talebi, Leila Azimi, Abdolaziz Rastegar Lari
Jundishapur Journal of Microbiology.2014;[Epub] CrossRef - Characterization of Acinetobacter baumannii Clinical Isolates Carrying blaOXA-23 Carbapenemase and 16S rRNA Methylase armA genes in Yemen
Sofiane Bakour, Samer Ahmed Alsharapy, Abdelaziz Touati, Jean-Marc Rolain
Microbial Drug Resistance.2014; 20(6): 604. CrossRef - First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals
Sofiane Bakour, Abdelaziz Touati, Taous Bachiri, Farida Sahli, Djamel Tiouit, Malek Naim, Mounia Azouaou, Jean-Marc Rolain
Journal of Infection and Chemotherapy.2014; 20(11): 696. CrossRef
- Gene Expression and Identification Related to Fluconazole Resistance of Candida glabrata Strains
-
Jae Il Yoo, Chi Won Choi, Kyeong Min Lee, Yeong Seon Lee
-
Osong Public Health Res Perspect. 2010;1(1):36-41. Published online December 31, 2010
-
DOI: https://doi.org/10.1016/j.phrp.2010.12.009
-
-
3,266
View
-
19
Download
-
10
Crossref
-
Abstract
PDF
- Objectives
Candida glabrata has become one of the most common causes of Candida bloodstream infections worldwide. Some strains of C. glabrata may be intermediately resistant to all azoles. The several possible mechanisms of azole resistance have been reported previously, but the exact resistant mechanism is not clear. In this study, we identified differentially expressed genes (DEGs) of fluconazole-resistant C. glabrata and compared the gene expression of fluconazole-resistant strains with that of fluconazole-susceptible strains to identify gene corresponding to fluconazole resistance.
Methods
Using antifungal susceptibility test, several C. glabrata strains were selected and used for further study. The expression of CgCDR1 and CgCDR2 genes was investigated by slot hybridization against fluconazole-susceptible, -resistant, and resistant-induced strains. In addition, ERG3 and ERG11 genes were sequenced to analyze DNA base substitution. DEGs were identified by reverse transcription-polymerase chain reaction using DEG kit composed of 120 random primers.
Results
In slot hybridization, CgCDR1 gene was expressed more than CgCDR2 gene in resistant strains. Though base substitution of ERG11 and ERG3 genes was observed in several base sequences, just one amino acid change was identified in resistant strain. In the results of reverse transcription-polymerase chain reaction, 44 genes were upregulated and 34 genes were downregulated. Among them, adenosine triphosphate-binding cassette transporter-related genes, fatty acid desaturase, lyase, and hypothetical protein genes were upregulated and aldehyde dehydrogenase, oxidoreductase, and prohibitin-like protein genes were downregulated. Other DEGs were also identified.
Conclusion
This study showed that CgCDR1 gene was more closely related to fluconazole resistance of C. glabrata than CgCDR2 gene. In addition, several other genes related with fluconazole resistance of C. glabrata were identified.
-
Citations
Citations to this article as recorded by - Two promising Bacillus-derived antifungal lipopeptide leads AF4 and AF5 and their combined effect with fluconazole on the in vitro Candida glabrata biofilms
Madduri Madhuri, Shivaprakash M. Rudramurthy, Utpal Roy
Frontiers in Pharmacology.2024;[Epub] CrossRef - Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Karolina M. Czajka, Krishnan Venkataraman, Danielle Brabant-Kirwan, Stacey A. Santi, Chris Verschoor, Vasu D. Appanna, Ravi Singh, Deborah P. Saunders, Sujeenthar Tharmalingam
Cells.2023; 12(22): 2655. CrossRef - Candida glabrata: Pathogenicity and Resistance Mechanisms for Adaptation and Survival
Yahaya Hassan, Shu Yih Chew, Leslie Thian Lung Than
Journal of Fungi.2021; 7(8): 667. CrossRef - Candidiasis and Mechanisms of Antifungal Resistance
Somanon Bhattacharya, Sutthichai Sae-Tia, Bettina C. Fries
Antibiotics.2020; 9(6): 312. CrossRef -
A Transcriptomics Approach To Unveiling the Mechanisms of
In Vitro
Evolution towards Fluconazole Resistance of a
Candida glabrata
Clinical Isolate
Mafalda Cavalheiro, Catarina Costa, Ana Silva-Dias, Isabel M. Miranda, Can Wang, Pedro Pais, Sandra N. Pinto, Dalila Mil-Homens, Michiyo Sato-Okamoto, Azusa Takahashi-Nakaguchi, Raquel M. Silva, Nuno P. Mira, Arsénio M. Fialho, Hiroji Chibana, Acácio G. R
Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef - Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium
Berdieke Goemaere, Katrien Lagrou, Isabel Spriet, Marijke Hendrickx, Pierre Becker
Antimicrobial Agents and Chemotherapy.2018;[Epub] CrossRef - Candida antifungal drug resistance in sub-Saharan African populations: A systematic review
Charlene Wilma Joyce Africa, Pedro Miguel dos Santos Abrantes
F1000Research.2017; 5: 2832. CrossRef - Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata
Atefeh Abdollahi Gohar, Hamid Badali, Tahereh Shokohi, Mojtaba Nabili, Nasrin Amirrajab, Maryam Moazeni
Mycopathologia.2017; 182(3-4): 273. CrossRef - Glabridin induces overexpression of two major apoptotic genes, MCA1 and NUC1 , in Candida albicans
Mojtaba Nabili, Maryam Moazeni, Mohammad Taghi Hedayati, Parisa Aryamlo, Atefeh Abdollahi Gohar, Seyed Mehdi Madani, Hamed Fathi
Journal of Global Antimicrobial Resistance.2017; 11: 52. CrossRef - Candida antifungal drug resistance in sub-Saharan African populations: A systematic review
Charlene Wilma Joyce Africa, Pedro Miguel dos Santos Abrantes
F1000Research.2016; 5: 2832. CrossRef
|
